APOTEX PTY LTD. — Irbesartan Importer Profile
Pharmaceutical Importer · #7 buyer for Irbesartan · $2.0M import value · 64 shipments · AUSTRALIA · DGFT Verified
APOTEX PTY LTD. is the #7 importer of Irbesartan from India with $2.0M in import value and 64 verified shipments. APOTEX PTY LTD. holds a 2.9% market share in Irbesartan imports based in AUSTRALIA. The company sources from 1 verified supplier across 48 formulations shipped to 1 country.
APOTEX PTY LTD. — Irbesartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Irbesartan to APOTEX PTY LTD.?
Verified from 64 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED | $2.0M | 64 | 100.0% |
APOTEX PTY LTD. sources Irbesartan from 1 verified Indian supplier based on 64 customs records. The primary supplier is ALEMBIC PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does APOTEX PTY LTD. Compare to Nearest Irbesartan Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MACLEODS PHARMA USA INC | UNITED STATES | $3.7M | 93 | $39.6K |
| 7 | APOTEX PTY LTD. ★ | AUSTRALIA | $2.9M | 57 | $50.0K |
| 8 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $2.6M | 144 | $18.0K |
| 2 | MACLEODS PHARMA USA,INC, | UNITED STATES | $2.5M | 49 | $50.0K |
APOTEX PTY LTD. ranks #7 among 366 Irbesartan importers from India. Average shipment value of $50.0K compared to the market average of $68.3K. The closest competitors by value are MACLEODS PHARMA USA INC and YUSEN LOGISTICS BENELUX BELGIUM.
Where Does APOTEX PTY LTD. Import Irbesartan To?
Destination countries from 64 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $2.0M | 64 | 100.0% |
APOTEX PTY LTD. imports Irbesartan to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $2.0M.
What Irbesartan Formulations Does APOTEX PTY LTD. Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO IRBESARTAN TAB 300 MG 2X15_AU | $149.6K | 3 |
| IRBESARTAN Tablets 300 MG | $100.0K | 2 |
| APO IRBE+HCTZ TAB 300/12.5 MG 2X15_AU IRBESARTAN & HYDROCHLOROTHIAZIDE TABLETS USP 300/12.5 MG | $90.2K | 3 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLE | $84.7K | 2 |
| APO IRBESARTAN TAB 150 MG 2X15_AU | $72.7K | 6 |
| IRBESARTAN TAB 150 MG (QTY: 22080*30 = 6 | $50.0K | 1 |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE 300/2 | $50.0K | 1 |
| APO IRBESARTAN TAB 150 MG 2X15_ AU | $50.0K | 1 |
| APO IRBESARTAN TAB 300 MG 2X15_AU [2X15 | $50.0K | 1 |
| IRBESARTAN TABLETS 150 MG (979200 TABS) | $50.0K | 1 |
APOTEX PTY LTD. imports 48 distinct Irbesartan formulations from India. The top formulation is APO IRBESARTAN TAB 300 MG 2X15_AU with 3 shipments worth $149.6K.
Regulatory Requirements: Importing Irbesartan into Australia
What APOTEX PTY LTD. and other importers must comply with to import Irbesartan from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Irbesartan
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Irbesartan from India and How Much Does APOTEX PTY LTD. Import?
India exported $25.0M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. APOTEX PTY LTD. imports $2.0M of this total, accounting for 2.9% of India's Irbesartan exports with 64 shipments from AUSTRALIA. This is verified from 64 customs shipment records covering 48 distinct formulations.
What Is the Average Order Value for APOTEX PTY LTD.'s Irbesartan Imports?
APOTEX PTY LTD.'s average Irbesartan order value is $30.8K per consignment, based on 64 shipments totaling $2.0M. APOTEX PTY LTD. is based in AUSTRALIA and ranks #7 among all Irbesartan importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Irbesartan to APOTEX PTY LTD.?
APOTEX PTY LTD. sources Irbesartan from 1 verified Indian supplier: ALEMBIC PHARMACEUTICALS LIMITED ($2.0M, 100.0%). This is based on 64 customs records.
How Does APOTEX PTY LTD. Compare to Other Irbesartan Importers?
APOTEX PTY LTD. ranks #7 among 366 Irbesartan importers from India with a 2.9% market share. The top 3 importers are MACLEODS PHARMA USA INC ($3.7M), APOTEX PTY LTD. ($2.9M), YUSEN LOGISTICS BENELUX BELGIUM ($2.6M). APOTEX PTY LTD. processed 64 shipments from AUSTRALIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX PTY LTD. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX PTY LTD.'s capped import value divided by total capped export value for Irbesartan across all Indian exporters.
- 5.Verified Records: This page is backed by 64 individual customs records matching APOTEX PTY LTD. importing Irbesartan, covering 48 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Import Data for APOTEX PTY LTD.
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX PTY LTD.'s Irbesartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX PTY LTD.
Company Profile
Multiple products · $0 total trade · Multiple categories
APOTEX PTY LTD. × Irbesartan
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX PTY LTD..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current order-level data, contact TransData Nexus.